nach oben

Journal of Behavioral Medicine

Erschienen in:

01.02.2007

Associations among Salivary Cortisol, Melatonin, Catecholamines, Sleep Quality and Stress in Women with Breast Cancer and Healthy Controls

verfasst von: Linda E. Carlson, Tavis S. Campbell, Sheila N. Garland, Paul Grossman

Erschienen in: Journal of Behavioral Medicine | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Dysregulations in several biological systems in breast cancer patients have been reported, including abnormalities in endocrine and sympathetic nervous system indices, as well as psychological disturbances and sleep disorders. The purpose of this exploratory study was to compare women with breast cancer to healthy control women on measures of salivary cortisol, urinary catecholamines, overnight urinary melatonin, and self-reported sleep quality, symptoms of stress, depression, anxiety and mood disturbance, to determine if discernable patterns of dysregulations across systems were apparent. Thirty-three women were tested in each group, with an average age of approximately 52 years, primarily Caucasian and well-educated. Forty percent of the women with breast cancer had stage 2 disease and they were an average of 1.36 years post-diagnosis. Women with breast cancer had significantly higher levels of disturbance on all the psychological indices, but there were no differences between groups on any of the biological measures, with the exception that the control women had higher dopamine values than the participants with breast cancer. None of the psychological scores were correlated with the biological measures. These results are consistent with other studies of early-stage breast cancer and highlight the importance of considering disease characteristics when investigating endocrine and sympathetic nervous system functioning.

Abercrombie, H. C., Giese-Davis, J., Sephton, S., Epel, E. S., Turner-Cobb, J. M., and Spiegel, D. (2004). Flattened cortisol rhythms in metastatic breast cancer patients. psychoneuroendocrinology 29: 1082–1092.PubMedCrossRef

Andersen, B. L., Kiecolt-Glaser, J. K., and Glaser, R. (1994). A biobehavioral model of cancer stress and disease course. Am. Psychol. 49: 389–404.PubMedCrossRef

Antoni, M. H. (2003). Psychoneuroendocrinology and psychoneuroimmunology of cancer: Plausible mechanisms worth pursuing? Brain Behav. Immun. 17(1): S84–S91.PubMedCrossRef

Bettermann, H., Kroz, M., Girke, M., and Heckmann, C. (2001). Heart rate dynamics and cardiorespiratory coordination in diabetic and breast cancer patients. Clin. Physiol. 21: 411–420.PubMedCrossRef

Bovbjerg, D. H. (2003). Circadian disruption and cancer: sleep and immune regulation. Brain Behav. Immun. 17(1): S48–S50.PubMedCrossRef

Bower, J. E., Ganz, P. A., Aziz, N., and Fahey, J. L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom. Med 64: 604–611.PubMed

Bower, J. E., Ganz, P. A., Dickerson, S. S., Petersen, L., Aziz, N., and Fahey, J. L. (2005). Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 30: 92–100.PubMedCrossRef

Bubenik, G. A., Blask, D. E., Brown, G. M., Maestroni, G. J., Pang, S. F., Reiter, R. J., et al. (1998). Prospects of the clinical utilization of melatonin. Biol. Signals Recep. 7: 195–219.CrossRef

Buysse, D. J., Reynolds, C. F., Monk, T. H., and Berman, S. R. (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatr. Res. 28: 193–213.CrossRef

Carlson, L. E., and Garland, S. N. (2005). Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int. J. Behav. Med. 12: 278–285.PubMedCrossRef

Carlson, L. E., Speca, M., Patel, K. D., and Goodey, E. (2003). Mindfulness-based stress reduction in relations to quality of life, mood, symptoms and stress and immune parameters in breast and prostate cancer outpatients. Psychosom. Med. 65: 571–581.PubMedCrossRef

Carlson, L. E., Speca, M., Patel, K. D., and Goodey, E. (2004). Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone-Sulftate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 29: 448–474.PubMedCrossRef

Carpenter, J. S., and Andrykowski, M. A. (1998). Psychometric evaluation of the Pittsburgh Sleep Quality Index. J. Psychosom. Res 45: 5–13.PubMedCrossRef

Cassileth, B. R., Lusk, E. J., Strouse, T. B., Miller, D. S., Brown, L. L., and Cross, P. A. (1985). A psychological analysis of cancer patients and their next-of-kin. Cancer 55: 72–76.PubMedCrossRef

Chambers, M. J., and Kim, J. Y. (1993). The role of state-trait anxiety in insomnia and daytime restedness. Behav. Med. 19: 42–46.PubMedCrossRef

Claghorn, J. L., Mathew, R. J., Weinman, M. L., and Hruska, N. (1981). Daytime sleepiness in depression. J. Clin. Psychiatr. 42: 342–343.

Cohen, S., and Williamson, G. M. (1991). Stress and infectious diseases in humans. Psychol. Bull. 109: 5–24.PubMedCrossRef

Cowan, M. J., Graham, K. Y., and Cochrane, B. L. (1992). Comparison of a theory of quality of life between myocardial infarction and malignant melanoma: a pilot study. Progr. Cardiovasc. Nurs. 7: 18–28.

Davidson, R., and MacKinnon, J. G. (1993). Estimation and Inference in Econometrics. Oxford University Press Oxford, England.

Davis, S., Mirick, D. K., and Stevens, R. G. (2001). Night shift work, light at night, and risk of breast cancer. J. Nati. Cancer Inst. 93: 1557–1562.CrossRef

Drafta, D. S., Stroe, E., Schindler, E. E., Teodosiu, T., Gozariu, L., and Drafta, D. (1981). Adrenal function in early and metastatic breast cancer: dexamethasone suppression of plasma cortisol. Endocrinologie 19: 115–121.PubMed

Edwards, S., Hucklebridge, F., Clow, A., and Evans, P. (2003). Components of the diurnal cortisol cycle in relation to upper respiratory symptoms and perceived stress. Psychosom. Med. 65: 320–327.PubMedCrossRef

Geoffriau, M., Brun, J., Chazot, G., and Claustrat, B. (1998). The physiology and pharmacology of melatonin in humans. Horm. Res. 49: 136–141.PubMedCrossRef

Gold, S. M., Zakowski, S. G., Valdimarsdottir, H. B., and Bovbjerg, D. H. (2003). Stronger endocrine responses after brief psychological stress in women at familial risk of breast cancer. Psychoneuroendocrinology 28: 584–593.PubMedCrossRef

Hall, M., Buysse, D. J., Nowell, P. D., Nofzinger, E. A., Houck, P., Reynolds, C. F., III, et al. (2000). Symptoms of stress and depression as correlates of sleep in primary insomnia. Psychosom. Med. 62: 227–230.PubMed

Hays, J. H., and O’Brian, J. T. (1989). Endocrine and metabolic function in patients with neoplastic disease. In Herberman, R. B. (Ed.), Influence of the Host on Tumor Development (pp. 530–543). Kluwer Academic Publishers, Dordrecht.

Hewitt, M., Rowland, J. H., and Yancik, R. (2003). Cancer survivors in the United States: age, health, and disability. J. Gerontol. A Biol. Sci. Med. Sci. 58: 82–91.PubMed

Hossain, J. L., and Shapiro, C. M. (2002). The prevalence, cost implications, and management of sleep disorders: an overview. Sleep Breath. 6: 85–102.PubMedCrossRef

James, G. D., Berge-Landry, H. H., Valdimarsdottir, H. B., Montgomery, G. H., and Bovbjerg, D. H. (2004). Urinary catecholamine levels in daily life are elevated in women at familial risk of breast cancer. Psychoneuroendocrinology 29: 831–838.PubMedCrossRef

James, G. D., Sealey, J. E., Alderman, M., Ljungman, S., Mueller, F. B., Pecker, M. S., et al. (1988). A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am. J. Hypertens 1: 124–131.PubMed

Kajimura, N., Kato, M., Sekimoto, M., Watanabe, T., Takahashi, K., Okuma, T., et al. (1998). A polysomnographic study of sleep patterns in normal humans with low- or high-anxiety personality traits. Psychiatr. Clin. Neurosci. 52: 317–320.CrossRef

Kirschbaum, C., and Hellhammer, D. H. (1994). Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19: 313–333.PubMedCrossRef

Koopman, C., Nouriani, B., Erickson, V., Anupindi, R., Butler, L. D., Bachmann, M. H., et al. (2002). Sleep disturbances in women with metastatic breast cancer. Breast J. 8: 362–370.PubMedCrossRef

Kripke, D. F., Garfinkel, L., Wingard, D. L., Klauber, M. R., and Marler, M. R. (2002). Mortality associated with sleep duration and insomnia. Archives Gen. Psychiatr. 59: 131–136.CrossRef

Kushida, C. A., Nichols, D. A., Simon, R. D., Young, T., Grauke, J. H., Britzmann, J. B., et al. (2000). Symptom-Based Prevalence of Sleep Disorders in an Adult Primary Care Population. Sleep Breath. 4: 9–14.PubMedCrossRef

Leckie, M. S., and Thompson, E. (1979). Symptoms of Stress Inventory. University of Washington. Ref Type: Serial (Book,Monograph), Seattle, WA.

Linsell, C. R., Lightman, S. L., Mullen, P. E., Brown, M. J., and Causon, R. C. (1985). Circadian rhythms of epinephrine and norepinephrine in man. J. Clin. Endocrinol. Metab 60: 1210–1215.PubMedCrossRef

Lissoni, P., Barni, S., Mandala, M., Ardizzoia, A., Paolorossi, F., Vaghi, M., et al. (1999a). Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur. J. Cancer 35: 1688–1692.PubMedCrossRef

Lissoni, P., Cazzaniga, M., Tancini, G., Scardino, E., Musci, R., Barni, S., et al. (1997). Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: Efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone. Eur. Urology 31: 178–181.

Lissoni, P., Tancini, G., Paolorossi, F., Mandala, M., Ardizzoia, A., Malugani, F., et al. (1999b). Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study. J Pineal Res. 26: 169–173.PubMedCrossRef

Lutgendorf, S. K., and Costanzo, E. S. (2003). Psychoneuroimmunology and health psychology: an integrative model. Brain Behav. Immun. 17: 225–232.PubMedCrossRef

Marshall, G. D., Jr., Agarwal, S. K., Lloyd, C., Cohen, L., Henninger, E. M., and Morris, G. J. (1998). Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav. Immun. 12: 297–307.PubMedCrossRef

McNair, D. A., Lorr, M., and Droppelman, L. F. (1971). Profile of Mood States . Educational and Industrial Testing Service, San Diego.

Mormont, M. C., and Levi, F. (1997). Circadian-system alterations during cancer processes: a review. Int J Cancer, 70 : 241–247.PubMedCrossRef

Pollack, L. A., Greer, G. E., Rowland, J. H., Miller, A., Doneski, D., Coughlin, S. S., et al. (2005). Cancer survivorship: a new challenge in comprehensive cancer control. Cancer Causes Control 16(1): 51–59.PubMedCrossRef

Porter, L. S., Mishel, M., Neelon, V., Belyea, M., Pisano, E., and Soo, M. S. (2003). Cortisol levels and responses to mammography screening in breast cancer survivors: a pilot study. Psychosom. Med. 65: 842–848.PubMedCrossRef

Pruessner, J. C., Kirschbaum, C., Meinlschmid, G., and Hellhammer, D. H. (2003). Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28: 916–931.PubMedCrossRef

Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Appl. Psychol. Measurement 1: 385–401.

Saez, M. C., Barriga, C., Garcia, J. J., Rodriguez, A. B., Masot, J., Duran, E., et al. (2005). Melatonin increases the survival time of animals with untreated mammary tumours: neuroendocrine stabilization. Mol. Cell Biochem. 278: 15–20.PubMedCrossRef

Savard, J., and Morin, C. M. (2001). Insomnia in the context of cancer: a review of a neglected problem. J. Clin. Oncol. 19: 895–908.PubMed

Savard, J., Simard, S., Blanchet, J., Ivers, H., and Morin, C. M. (2001). Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 24: 583–590.PubMed

Schernhammer, E. S., Laden, F., Speizer, F. E., Willett, W. C., Hunter, D. J., Kawachi, I., et al. (2001). Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J. Nati. Cancer Institute 93: 1563–1568.

Sephton, S., and Spiegel, D. (2003). Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav. Immun. 17: 321–328.PubMedCrossRef

Sephton, S. E., Sapolsky, R. M., Kraemer, H. C., and Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Nati. Cancer Inst. 92: 944–1000.

Shapiro, S. L., Bootzin, R. R., Figueredo, A. J., Lopez, A. M., and Schwartz, G. E. (2003). The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. J. Psychosom. Res. 54: 85–91.PubMedCrossRef

Shapiro, S. L. (2001). Quality of life and breast cancer: Relationship to psychosocial variables. J. Clin. Psychol. 57: 501–519.PubMedCrossRef

Sikes, C. R. A., and Lasley, B. J. (1989). Cognitive sequelae of hypothalamic-pituitary-adrenal (HPA) dysregulation in depression. Biol. Psychiatr. 25: 148A–149A.CrossRef

Speca, M., Carlson, L. E., Goodey, E., and Angen, M. (2000). A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom. Med. 62: 613–622.PubMed

Speilberger, C. D. (1983). Manual for the State-Trait Anxiety Inventory: STAI (Form Y). Consulting Psychologists Press, Palo Alto, CA.

Spiegel, D., and Sephton, S. E. (2001). Psychoneuroimmune and endocrine pathways in cancer: effects of stress and support. Semin. Clini. Neuropsychiatr. 6: 252–265.CrossRef

Spiegel, D., Sephton, S. E., Terr, A. I., and Sittes, D. P. (1998). Effects of psychosocial treatment in prolonging cancer survival may be mediated by neuroimmune pathways. Ann. New York Acad. Sci. 840: 674–683.CrossRef

Tamarkin, L., Danforth, D., Lichter, A., DeMoss, E., Cohen, M., Chabner, B., et al. (1982). Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 216: 1003–1005.PubMedCrossRef

Ticher, A., Haus, E., Ron, I. G., Sackett-Lundeen, L., and Ashkenazi, I. E. (1996). The pattern of hormonal circadian time structure (acrophase) as an assessor of breast-cancer risk. Int. J. Cancer 65: 591–593.PubMedCrossRef

Touitou, Y., Bogdan, A., Levi, F., Benavides, M., and Auzeby, A. (1996). Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens. Br. J. Cancer 74: 1248–1252.PubMed

Turner-Cobb, J. M., Sephton, S. E., Koopman, C., Blake-Mortimer, J., and Spiegel, D. (2000). Social support and salivary cortisol in women with metastatic breast cancer. Psychosom. Med. 62: 337–345.PubMed

van Der Pompe, G., Antoni, M. H., and Heijnen, C. J. (1996). Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 21: 361–374.PubMedCrossRef

Vedhara, K., Miles, J., Bennett, P., Plummer, S., Tallon, D., Brooks, E., et al. (2003). An investigation into the relationship between salivary cortisol, stress, anxiety and depression. Biol. Psychol. 62: 89–96.PubMedCrossRef

Vedhara, K., Stra, J. T., Miles, J. N., Sanderman, R., and Ranchor, A. V. (2006). Psychosocial factors associated with indices of cortisol production in women with breast cancer and controls. Psychoneuroendocrinology, 31: 299–311.PubMedCrossRef

Vijayalaxmi, Meltz, M. L., Reiter, R. J., and Herman, T. S. (1999). Melatonin and protection from genetic damage in blood and bone marrow: whole-body irradiation studies in mice. J. Pineal Res. 27: 221–225.

Vijayalaxmi, Reiter, R. J., Meltz, M. L., and Herman, T. S. (1998). Melatonin: possible mechanisms involved in its ‘radioprotective’ effect. Mutation Res. 404: 187–189.

Vijayalaxmi, Thomas, C. R., Jr., Reiter, R. J., and Herman, T. S. (2002). Melatonin: from basic research to cancer treatment clinics. J Clin. Oncology 20: 2575–2601.

White, I. R., Brunner, E. J., and Barron, J. L. (1995). A comparison of overnight and 24 hour collection to measure urinary catecholamines. J. Clin. Epidemiology 48: 263–267.CrossRef

Wolkowitz, O. M. (1994). Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 3: 233–255.CrossRef

Titel: Associations among Salivary Cortisol, Melatonin, Catecholamines, Sleep Quality and Stress in Women with Breast Cancer and Healthy Controls
verfasst von: Linda E. Carlson
Tavis S. Campbell
Sheila N. Garland
Paul Grossman
Publikationsdatum: 01.02.2007
Verlag: Kluwer Academic Publishers-Plenum Publishers
Erschienen in: Journal of Behavioral Medicine / Ausgabe 1/2007
Print ISSN: 0160-7715
Elektronische ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-006-9082-3

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Perceived Ethnic Discrimination in Relation to Daily Moods and Negative Social Interactions

Specificity of Social Support for Back Pain Patients: Do Patients Care Who Provides What?

Effects of Opioid Blockade with Naltrexone and Distraction on Cold and Ischemic Pain in Hypertension

Hostility, Anger, and Marital Adjustment: Concurrent and Prospective Associations with Psychosocial Vulnerability